Performance analysis of Gyre Therapeutics (GYRE)
Annual Return
Over the past 3 years, GYRE has had an average annual return of -2.44%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, GYRE has had an average annual return of -7.55%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, GYRE has had an average annual return of -17.49%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Apr 12, 2006, GYRE has had an average annual return of -22.84%, underperforming the benchmark SPY, which returned +11.08% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.75% | -41.35% | -53.15% | +516.67% | +125% | -85.59% | -6.72% | -13.77% | -42.26% | +39.77% | -79.20% | -72.93% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
| -36.62% | -5.26% | -21.36% | -78.98% | +26.79% | +487.06% | -56.90% | -8.73% | +4.50% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +14.75% | +1.43% | -15.49% | +10% | -22.73% | +11.76% | -8.77% | -14.75% | |||||
| 2025 | -4.81% | +1.01% | -33.00% | +25.37% | -7.14% | -19.23% | -3.17% | +9.84% | -4.48% | +4.69% | -0% | -8.96% | -41.35% |
| 2024 | -51.80% | +45.79% | -3.21% | -10.60% | -27.41% | +5.10% | +21.36% | -4.80% | -9.24% | +13.89% | -12.20% | -3.70% | -53.15% |
| 2023 | -0% | +5.56% | -28.95% | +0% | +3.70% | +60.71% | +8.89% | +46.94% | -13.89% | -6.45% | +250% | +9.36% | +516.67% |
| 2022 | -37.50% | +10% | +9.09% | -33.33% | +175% | +40.91% | -0% | +12.90% | -2.86% | +5.88% | +5.56% | -5.26% | +125% |
| 2021 | -10.81% | +7.07% | -16.98% | -0% | -14.77% | +1.33% | -6.58% | +12.68% | -10.00% | -19.44% | -63.79% | -23.81% | -85.59% |
| 2020 | +4.20% | -18.55% | -23.76% | +37.66% | +18.87% | -18.25% | -12.62% | +1.11% | -17.58% | +28% | +13.54% | +1.83% | -6.72% |
| 2019 | +11.59% | -3.25% | -4.70% | +7.75% | -9.80% | -6.52% | +10.85% | -21.68% | -23.21% | +10.47% | -0% | +25.26% | -13.77% |
| 2018 | +86.19% | -0.45% | +2.03% | +10.40% | -13.43% | -52.78% | -15.20% | +10.40% | -1.05% | -17.46% | +19.87% | -26.20% | -42.26% |
| 2017 | -11.11% | -21.71% | +38.66% | -43.64% | -10.75% | -2.41% | -11.11% | -18.06% | +50.85% | -3.37% | +41.86% | +95.90% | +39.77% |
Drawdown analysis of Gyre Therapeutics (GYRE)
The maximum drawdown for the GYRE was -99.98%, occurring on May 10, 2022. This drawdown has not yet recovered.
The current GYRE drawdown is -99.85%.
Since Apr 12, 2006 GYRE has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 6 times
- 10% or more: 12 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.98% | Mar 3, 2011 | 2816 | May 10, 2022 | Ongoing | Ongoing | Ongoing |
| -84.90% | Jul 27, 2007 | 340 | Dec 1, 2008 | 164 | Jul 28, 2009 | 504 |
| -38.22% | Apr 12, 2006 | 103 | Sep 11, 2006 | 75 | Dec 27, 2006 | 178 |
| -25.88% | May 3, 2010 | 81 | Aug 26, 2010 | 41 | Oct 25, 2010 | 122 |
| -21.70% | Dec 4, 2009 | 69 | Mar 17, 2010 | 29 | Apr 28, 2010 | 98 |
| -20.27% | Oct 16, 2009 | 8 | Oct 28, 2009 | 18 | Nov 23, 2009 | 26 |
| -19.38% | Oct 7, 2009 | 3 | Oct 12, 2009 | 4 | Oct 16, 2009 | 7 |
| -15.74% | Nov 4, 2010 | 17 | Nov 30, 2010 | 12 | Dec 16, 2010 | 29 |
| -15.72% | Feb 23, 2007 | 21 | Mar 26, 2007 | 20 | Apr 24, 2007 | 41 |
| -13.66% | Jul 29, 2009 | 3 | Aug 3, 2009 | 4 | Aug 7, 2009 | 7 |
| -11.04% | Sep 30, 2009 | 1 | Oct 1, 2009 | 4 | Oct 7, 2009 | 5 |
| -11.02% | May 22, 2007 | 29 | Jul 3, 2007 | 17 | Jul 27, 2007 | 46 |
| -9.23% | Jan 14, 2011 | 5 | Jan 24, 2011 | 24 | Feb 28, 2011 | 29 |
| -7.93% | Jan 3, 2007 | 27 | Feb 12, 2007 | 8 | Feb 23, 2007 | 35 |
| -7.04% | Dec 1, 2009 | 2 | Dec 3, 2009 | 1 | Dec 4, 2009 | 3 |
| -6.30% | Aug 14, 2009 | 4 | Aug 20, 2009 | 5 | Aug 27, 2009 | 9 |
| -5.30% | Apr 24, 2007 | 2 | Apr 26, 2007 | 2 | Apr 30, 2007 | 4 |
| -4.87% | Apr 30, 2007 | 9 | May 11, 2007 | 7 | May 22, 2007 | 16 |
| -3.81% | Nov 23, 2009 | 3 | Nov 27, 2009 | 1 | Nov 30, 2009 | 4 |
| -2.95% | Aug 10, 2009 | 1 | Aug 11, 2009 | 3 | Aug 14, 2009 | 4 |
| -2.90% | Sep 8, 2009 | 3 | Sep 11, 2009 | 2 | Sep 15, 2009 | 5 |
| -2.26% | Oct 29, 2010 | 1 | Nov 1, 2010 | 1 | Nov 2, 2010 | 2 |
| -2.21% | Dec 27, 2010 | 4 | Dec 31, 2010 | 6 | Jan 10, 2011 | 10 |
| -1.72% | Dec 21, 2010 | 1 | Dec 22, 2010 | 1 | Dec 23, 2010 | 2 |
| -1.51% | Aug 31, 2009 | 2 | Sep 2, 2009 | 1 | Sep 3, 2009 | 3 |